Letters to the Editor

Barnes TR McPhilips MA . Novel antipsychotics, extrapyramidal side effects and tardive dyskinesia. Int Clin Psychopharmacol 1998;13 Suppl 3:S49–S57.

Woeraer MG Sheitman BB Lieberman JA Kane JM . Tardive dyskinesia induced by risperidone? [letter]. Am J Psychiatry 1996;153:843.

Dave M . Clozapine–related tardive dyskinesia. Biol Psychiatry 1994;35:886–7.

Tollefson GD Beasley CMJ Tamura RN Tran PV Potvin JH . Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol. Am J Psychiatry 1997;154:1248–54.

Soutullo CA Keck PEJ McElroy SL . Olanzapine in the treatment of tardive dyskinesia: A report of two cases [letter], J Clin Psychopharmacol 1999;19:100–101.

Jeste DV Caligiuri MP . Tardive dyskinesia. Schizophr Bull 1993;19:303–15.

Lam RW Bartley S Yatham LN Tarn EM Zis AP . Clinical predictors of short-term outcome in electroconvulsive therapy. Can J Psychiatry 1999;44:158–63.

Prudic J Sackeim HA Devanand DP . Medication resistance and clinical response to electroconvulsive therapy. Psychiatry Res 1990;31:287–96.

Prudic J Haskett RF Mulsant B Malone KM Pettinati HM , Stephens S, and others. Resistance to antidepressant medications and short-term clinical response to ECT. Am J Psychiatry 1996;153:985–92.

Kindler S Shapira B Hadjez J Abramowitz M Brom D Lerer B . Factors influencing response to bilateral electroconvulsive therapy in major depression. Convulsive Ther 1991;7:245–54.

Buchan H Johnstone E McPherson K Palmer RL Crow TJ Brandon S . Who benefits from electroconvulsive therapy? Combined results of the Leicester and North-wick Park trials. Br J Psychiatry 1992; 160:355–9.

Hickie I Mason C Parker G Brodaty H . Prediction of ECT responses: Validation of a refined sign-based (CORE) system for defining melancholia. Br J Psychiatry 1996;169:68–74.

O'Leary D Gill D Gregory S Shawcross C . Which depressed patients respond to ECT? The Nottingham results. J Affect Disord 1995;33:245–50.

Sobin C Prudic J Devanand DP Nobler MS Sackeim HA . Br J Psychiatry 1996;169:322–8.

Hamilton M . Electroconvulsive therapy. Indications and contraindications. Annals NY Acad Sci 1986;462:5–11.

Nobler MS Sackeim HA . Electroconvulsive therapy: Clinical and biological aspects. In: Goodnick PJ , editor. Predictors of treatment response in mood disorders. Washington (DC): American Psychiatric Press; 1995. p 177–98.

Zimmerman M Coryell W Pfohl B Corenthal C Stangl D . ECT response in depressed patients with and without a DSM-III personality disorder. Am J Psychiatry 1986;143:1030–2.

Black DW Bell S Hulbert J Nasrallah A . The importance of axis II in patients with major depression. A controlled study. J Affect Disord 1988;14:115–22.

Casey P Meagher D Butler E . Personality, functioning, and recovery from major depression. J Nerv Ment Dis 1996;184:240–5.

Sareen J Enns M W Guertin JE . The impact of clinically diagnosed personality disorders on acute and one year outcomes of electroconvulsive therapy. Journal of ECT. Forthcoming.

Enns MW Reiss JP . Electroconvulsive therapy. Can J Psychiatry 1992;37:671–8.

Lam RW Bartley S Yatham LN Tam EM Zis AP . Clinical predictors of short-term outcome in electroconvulsive therapy. Can J Psychiatry 1999;44:158–63.

Zimmerman M Coryell W Pfohl B Corenthal C Stangl D . ECT response in depressed patients with and without a DSM-III personality disorder. Am J Psychiatry 1986;143:1030–2.

Thase ME . The role of axis II comorbidity in the management of patients with treatment-resistant depression. Psychiatr Clin N Am 1996; 19:287–309.

Dawson DF . Treatment of the borderline patient, relationship management. Can S Psychiatry 1988;33:370–4.

Swenson CR Johnston Wood M . Issues involved in combining drugs with psychotherapy for the borderline inpatient. Psychiatr Clin N America 1990;13:297–306.

Quaytman M Sharfstein S . Treatment for severe borderline personality disorder in 1987 and 1997. Am J Psychiatry 1997; 154:1139–44.

Effexor product monograph. Wyeth-Ayerst Inc.

Kohn S Labbate LA . Venlafaxine and ecchymosis [letter]. Can J Psychiatry 1997;42:91.

Humphries JE, and others. Fluoxetine and the bleeding time. Arch Pathol Lab Med 1990;114:727–8.

Aranth J Lindberg C . Bleeding, a side effect of fluoxetine [letter]. Am J Psychiatry. 1992;149:412.

Ottervanger JP, and others. Bleeding attributed to the intake of paroxetine. Am J Psychiatry 1994;151:781–2.

Berk M, and others. Fluoxetine and hemostatic function: A pilot study. J Clin Psychiatry 1995;56:14–6.

Bakish D, and others. Effects of serotonin reuptake inhibitors on platelet serotonin parameters in major depressive disorder. 1997;41:184–90.

Skop BP Brown TM . Potential vascular and bleeding complications of treatment with selective serotonin reuptake inhibitors [review]. Psychosomatics. 1996;37:12–5.

Dickeman M . Demographic consequences of infanticide in man. Annual Review of Ecology and Systematics 1975;6:107–37.

Kau K . Were girl babies sacrificed to a folk superstition in 1966 in Japan? Ann Hum Biol 1975;2:391–3.

Rodenburg M . Child murder by depressed parents. Canadian Psychiatric Association Journal 1971;16:41–8.

Wilczynski A . Child homicide. London: Greenwich Medical Media; 1997.

Daly M Wilson M . Homicide. New York: Aldine de Gruyter; 1988.

Kunz B Bahr SJ . A profile of parental homicide against children. Journal of Family Violence 1996;11:347–62.

Marteau JD Roy R Laporte L Webanck T Poulin B . Homicide d'enfants commis par la mère. Can J Psychiatry 1995;40:142–9.

Lomis MJ . Maternal filicide: A preliminary examination of culture and victim sex. Int J Law Psychiatry 1986;9:503–6.

Cordier J . L'enfant, victime privilégiée du drame passionnel. Victimology 1983;1–2:131–6.

Kraus RP . Visual “trails” with nefazodone treatment. Am J Psychiatry 1996;153:1365–6.

Schwartz K . Nefazodone and visual side effects. Am J Psychiatry 1997;154:1038.

Gillis MC , editor. Compendium of pharmaceuticals and specialties. 33rd ed. Ottawa: Canadian Pharmaceutical Association; 1998. p 1534–8.

Ellingrod VL Perry PJ . Nefazodone: A new antidepressant. Am J Health-Syst Pharm 1995;52:2799–812.

Pourcho RG . Neurotransmitters in the retina. Curr Eye Res 1996;15:797–803.

Hughes MS Lessell S . Trazodone-induced palinopsia. Arch Ophthalmol 1990;108:399–400.

Von Moltke LL Greenblatt DJ , Grassi JM, and others. Protease inhibitors as inhibitors of human cytochromes P450: High risk associated with ritonavir. J Clin Pharmacol 1998;38:106–11.

Gillis MC , editor. Compendium of Pharmaceuticals and Specialties. 33rd ed. Ottawa: Canadian Pharmaceutical Association; 1998. p 1143–7.

Crenshaw TL Goldberg JP . Sexual pharmacology. Drugs that affect sexual function. New York: WW Norton & Company; 1996.

Thase ME Zajecka J , Kornstein SG, and others. Nefazodone treatment of patients with poor response to SSRIs. Presented at the 38th annual meeting of the New Clinical Drug Evaluation Unit (MCDEU); June 10, 1998; Boca Raton, FL.

Ashton AK Rosen RC . Accommodation to serotonin reuptake inhibitor-induced sexual dysfunction. J Sex Marital Ther 1998;24:191–2.

Ashton AK Hamer R Rosen RC . Serotonin reuptake inhibitor-induced sexual dysfunction and its treatment: A large scale retrospective study of 596 psychiatric outpatients. J Sex Marital Ther 1997;23:165–75.

Bartlik BD Kaplan P Kaplan HS . Psychostimulants, apparently reverse sexual dysfunction secondary to selective serotonin reuptake inhibitors. J Sex Marital Ther 1995;4:264–71.

Norden MD . Buspirone treatment of sexual dysfunction associated with SSRIs. Depression 1994;2:109–12.

Ashton AK Rosen RC . Bupropion as an antidote for serotonin reuptake inhibitor-induced sexual dysfunction. J Clin Psychiatry 1998;59:112–5.

Cohen AJ Bartlik B . Ginkgo biloba for antidepressant-induced sexual dysfunction. J Sex Marital Ther 1998;24:139–43.

Fava M Rankin MA Alpert JE Nierenberg AA Worthington JJ . An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998;67:328–31.

Nurnberg HG Lauriello J Hensley PL Parker LM Leith SJ . Sildenafil for Iatrogenic serotonergic antidepressant medication-induced sexual dysfunction in 4 patient. J Clin Psychiatry 1999;60:33–5.

Ashton AK Bennett RG . Sildenafil treatment of serotonin re-uptake inhibitor-induced sexual dysfunction [letter]. J Clin Psychiatry 1999;60:194–5.

Calabresse JR Kimmel SE Woyshville MJ Rapaport DJ Faust CJ , Thompson PA, and others. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759–64.

Antonacci DJ Swartz CM . Clozapine treatment of euphoric mania. Ann Clin Psychiatry 1995;7:203–6.

Zarate CA Jr Tohen M Baldessarini RJ . Clozapine in severe mood disorders. J Clin Psychiatry 1995;55:411–7.

Bylerly MJ Greer RA Evans DL . Behavioral stimulation associated with risperidone association. Am J Psychiatry 1995;152:1096–7.

Tomlinson C . Risperidone and mania. Am J Psychiatry 1996;153:132–3.

O'Croinin F Zibin T Holt L . Hypomania associated with risperidone. Can J Psychiatry 1995;40:51.

Dwight MM Keck PE Jr , Stanton SM, and others. Antidepressant activity and mania associated with risperidone treatment of schizoaffective disorder. Lancet 1994;344:554–5.

Schneirow BJ Graeber DA . Manic symptoms associated with initiation of risperidone. Am J Psychiatry 1996;153:1235–6.

Diaz SF . Mania associated with risperidone use. J Clin Psychiatry 1996;57:41–2.

Kock RJ Kessler CC . Probable induction of mania by risperidone. J Clin Psychiatry 1996;57(4):174–5.

Barkin JJ Pis VM Gaffney MR . Induction of mania by risperidone resistant to mood stabilizers. J Clin Psychopharmacol 1977;17:57–8.

Goodnick PJ . Risperidone treatment of refractory acute mania. J Clin Psychiatry 1995;56:431–2.

Tollefson GD Beasley CM , Tran PV, and others. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophrenic disorders: Result of an international trial. Am J Psychiatry 1997;465:154–7.

Sciacca K . An integrated treatment approach for severely mentally ill individuals with substance disorders. New Directions for Mental Health Services 1991;50:69–84.

Nigam R Schoftenfeld R Kosten R . Treatment of dual diagnosis patients: A relapse prevention group approach. Journal of Substance Abuse Treatment 1992;9:305–9.

Nyback H Wiesel FA Berggren BM Hindmarsh T . Computed tomography of the brain in patients with acute psychosis and in healthy volunteers. Acta Psychiatr Scand 1982;65:403–14.

Shelton RC Weinberger DR . X-ray computerized tomography studies in schizophrenia: A review and synthesis. In: Nasrallah HA Wienberger DR , editors. Handbook of schizophrenia. Volume 1: The neurology of schizophrenia. Amsterdam: Elsevier; 1986. p 207–50.

Rubin P Karle A Moller-Madsen S Hertel C Povlsen UJ , Noring U, and others. Computerised tomography in newly diagnosed schizophrenia and schizophreniform disorder. A controlled blind study. Br J Psychiatry 1993;163:604–12.

Lim KO Rosenbloom M Pfefferbaum A . In vivo structural brain assessment. In: Bloom FE Kupfer DJ , editors. Psychopharmacology: “the fourth generation of progress.” New York: Raven Press; 1995. p 881–94.

Andreasen NC . Neuroradiology and neuropsychiatry: A new alliance. AJNR 1992;13:841–3.